Press Releases

Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne

https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime

Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds

Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes.

Inceptua Group Expands Early Access Program to Latin America

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

Launch of a mutant RNA T7 polymerase with highly reduced double-stranded RNA formation

Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.

Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies

Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

LG UNVEILS ‘PRIMEFOCUS HEALTH,’ NEW VENTURE IN HOME HEALTHCARE TREATMENT

LG Electronics has launched “Primefocus Health,” a new venture that aims to leverage innovative technologies and new healthcare therapies to enable providers to deliver a personalized, complete care experience and empower individuals to take control of their health at home. This new provider-focused, patient-centric healthcare platform intends to give patients access to new healthcare therapies made available by innovative technology applications, as well as providers access to patient data and progress information to help ensure that their patients are on the right path to better health. Primefocus Health is the first new venture launched by LG NOVA, LG Electronics’ North America Innovation Center.

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long Covid Patients

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

Torbay Pharma strengthens leadership team to support North American growth strategy

Amerigo Scientific Adds Magnetic Silica Beads to Enlarge Its Nucleic Acid Extraction and Purification Toolbox

Cresset Targets Global Growth with New India HQ

Drug discovery specialist Cresset has announced a major milestone in its international growth with the launch of a new Indian HQ in Bangalore.

ECI Unveils Dynamic New Identity With A Fresh Vision for Global Leadership

ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company’s ongoing growth and dedication to innovation in the life sciences industry. This fundamental transformation includes a refreshed brand identity, focusing on a refined brand structure and elevated visual appeal.

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment, and growth management experience to his new role.

Sharp Services announces expansion in Pennsylvania to facilitate growth in sterile injectable market

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

Clinical Study Highlights Improvements to Gut Microbiome and Autism Spectrum Disorder Symptoms with Use of Custom Probiotics

Researchers with Sun Genomics and Arizona State University (ASU) have discovered that probiotic supplementation may improve symptoms in people with autism spectrum disorder. The joint metagenomics study assessed the effects of customized probiotic supplementation on children and adults with autism.

PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology Awards

Alfa Chemistry Rolls Out Various Nucleic Acid Delivery Options for Nucleotide Vaccine Research